CN-24-20: Introduction of a new Lyme’s disease/ Borellia burgdorferi IgG and IgM assay

In September 2024, UCD NVRL is introducing the AccuDiag™ B. burgdorferi VIsE1/pepC10 IgG/IgM assay for the further investigation of serum samples reactive using our screening assay, the DiaSorin Liaison™ B. burgdorferi IgG.

The AccuDiag™ assay is used in the Lyme Reference Laboratory in the Rare and Imported Pathogen Laboratory (RIPL) based in Porton Down, UK.

Samples reactive using both the Diasorin™ and AccuDiag™ assays will continue to be sent to RIPL, UK for confirmatory investigations.

If you have any queries in relation to this notification, please call the Clinical Team on 01-7164401